One Drop App With an Activity Tracker for Adults With Type 1 Diabetes: Randomized Controlled Trial

BACKGROUND: level of 22.2 mg/dL (-0.80%). However, the added value of integrated activity trackers is unknown. OBJECTIVE: level of adults with type 1 diabetes. METHODS: differences in intent-to-treat (ITT) and per protocol (PP) analyses. RESULTS: level (mean 7.9%, SD 0.59%, 95% CI 7.7-8.1) than that of participants in the One Drop only condition (mean 8.2%, SD 0.58%, 95% CI 8.0-8.4). CONCLUSIONS: level compared to that of participants exposed to One Drop only during the same timeframe. One Drop and a tracker may work better together than alone in helping people with type 1 diabetes. TRIAL REGISTRATION: ClinicalTrials.gov NCT03459573; https://clinicaltrials.gov/ct2/show/NCT03459573.